中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2015年
2期
48-50
,共3页
精蛋白锌重组赖脯胰岛素混合注射液%糖尿病%血糖波动
精蛋白鋅重組賴脯胰島素混閤註射液%糖尿病%血糖波動
정단백자중조뢰포이도소혼합주사액%당뇨병%혈당파동
Protamine zinc recombinant lispro insulin injection%Diabetes%Blood glucose fluctuation
目的:探讨精蛋白锌重组赖脯胰岛素混合注射液不同给药方案对老年2型糖尿病患者血糖波动的影响。方法选取2011年7月至2013年7月我院诊治的老年2型糖尿病患者50例,随机分为试验组与对照组,各25例。对照组患者给予精蛋白锌重组赖脯胰岛素混合注射液2次/d,试验组患者给予精蛋白锌重组赖脯胰岛素混合注射液3次/d;比较两组患者的血糖波动情况。结果试验组患者精蛋白锌重组赖脯胰岛素混合注射液日均总量为(41±8)U,对照组为(42±6)U,两组比较,差异无统计学意义(P>0.05)。试验组患者的血糖达标时间明显长于对照组;试验组患者平均血糖漂移幅度为(3.2±1.1)mmol/L,明显低于对照组的(5.4±1.7)mmol/L;试验组患者日间血糖平均绝对差为(1.7±0.8)mmol/L,明显低于对照组的(2.5±1.2)mmol/L;两组比较,差异均有统计学意义(P<0.05)。结论在血糖达标条件下,精蛋白锌重组赖脯胰岛素混合注射液3次/d与2次/d比较,日均胰岛素使用量无较大差异,但对血糖波动的影响相对较小,能减少低血糖的发生率。
目的:探討精蛋白鋅重組賴脯胰島素混閤註射液不同給藥方案對老年2型糖尿病患者血糖波動的影響。方法選取2011年7月至2013年7月我院診治的老年2型糖尿病患者50例,隨機分為試驗組與對照組,各25例。對照組患者給予精蛋白鋅重組賴脯胰島素混閤註射液2次/d,試驗組患者給予精蛋白鋅重組賴脯胰島素混閤註射液3次/d;比較兩組患者的血糖波動情況。結果試驗組患者精蛋白鋅重組賴脯胰島素混閤註射液日均總量為(41±8)U,對照組為(42±6)U,兩組比較,差異無統計學意義(P>0.05)。試驗組患者的血糖達標時間明顯長于對照組;試驗組患者平均血糖漂移幅度為(3.2±1.1)mmol/L,明顯低于對照組的(5.4±1.7)mmol/L;試驗組患者日間血糖平均絕對差為(1.7±0.8)mmol/L,明顯低于對照組的(2.5±1.2)mmol/L;兩組比較,差異均有統計學意義(P<0.05)。結論在血糖達標條件下,精蛋白鋅重組賴脯胰島素混閤註射液3次/d與2次/d比較,日均胰島素使用量無較大差異,但對血糖波動的影響相對較小,能減少低血糖的髮生率。
목적:탐토정단백자중조뢰포이도소혼합주사액불동급약방안대노년2형당뇨병환자혈당파동적영향。방법선취2011년7월지2013년7월아원진치적노년2형당뇨병환자50례,수궤분위시험조여대조조,각25례。대조조환자급여정단백자중조뢰포이도소혼합주사액2차/d,시험조환자급여정단백자중조뢰포이도소혼합주사액3차/d;비교량조환자적혈당파동정황。결과시험조환자정단백자중조뢰포이도소혼합주사액일균총량위(41±8)U,대조조위(42±6)U,량조비교,차이무통계학의의(P>0.05)。시험조환자적혈당체표시간명현장우대조조;시험조환자평균혈당표이폭도위(3.2±1.1)mmol/L,명현저우대조조적(5.4±1.7)mmol/L;시험조환자일간혈당평균절대차위(1.7±0.8)mmol/L,명현저우대조조적(2.5±1.2)mmol/L;량조비교,차이균유통계학의의(P<0.05)。결론재혈당체표조건하,정단백자중조뢰포이도소혼합주사액3차/d여2차/d비교,일균이도소사용량무교대차이,단대혈당파동적영향상대교소,능감소저혈당적발생솔。
Objective To investigate the protamine zinc recombinant insulin lispro mixed injection of different dosage regimen in patients with blood glucose fluctuation effect on elderly patients with type 2 diabetes melitus. Methods 50 elderly patients with type 2 diabetes from 2011 July to 2013 July in our hospital were randomly divided into experimental group and control group,each of 25 cases.Patients in control group were treated with protamine zinc recombinant lispro insulin injection 2 times a day,the test group were treated with protamine zinc recombinant lispro insulin injection 3 times a day;compared two groups of patients with blood glucose fluctuation.Results In the test group protamine zinc recombinant lispro insulin injection daily for the total(41±8)U,the control group(42±6)U,two groups,no significant difference(P>0.05).Blood glucose time of test group was longer than that in the control group;patients in experimental group mean amplitude of glycemic excursion for(3.2±1.1)mmol/L,significantly lower than the control group(5.4±1.7)mmol/L;in the test group blood sugar for daytime mean absolute difference (1.7±0.8)mmol/L,obviously lower than that of control group(2.5±1.2)mmol/L;the two groups,the difference was statisticaly significant(P<0.05).Conclusion In the glucose standard conditions,protamine zinc recombinant lispro insulin injection 3 times a day and 2 times a day to compare daily insulin use,without obvious difference,but the effect on blood sugar fluctuations is relatively smal,can reduce the incidence of hypoglycemia.